Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
about
Insidious changes in stromal matrix fuel cancer progressionSemaphorin 3A suppresses tumor growth and metastasis in mice melanoma modelCommon deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42A stromal gene signature associated with inflammatory breast cancer.SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.Demethylating Agents in the Treatment of CancerKLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.Regulation of fibulin-2 gene expression by integrin α3β1 contributes to the invasive phenotype of transformed keratinocytesBrg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1.AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancerOdontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.Anti-cancer role of SPARC, an inhibitor of adipogenesisIntegrated extracellular matrix signaling in mammary gland development and breast cancer progression.Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.Integrin β4 regulates SPARC protein to promote invasion.Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cellsLarge isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.The fibromatosis signature defines a robust stromal response in breast carcinoma.Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.Matricellular proteins as regulators of cancer metastasis to bone.Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model.Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expressionSPARC: a matricellular regulator of tumorigenesis.Stromal expression of SPARC in pancreatic adenocarcinoma.Role of SPARC in bone remodeling and cancer-related bone metastasis.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.Nab-paclitaxel in patients with metastatic melanoma.The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins.Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
P2860
Q26851261-006755A3-A069-414A-AA6C-1456E686236DQ27306612-8DC51AF3-7461-4D52-A76A-0153FC712B4FQ30157922-5912EB55-7A25-4734-A7A0-C6694909F313Q30423594-471F6BE7-AF50-4147-B93F-F80791E8ECA2Q30838525-1A5A0511-4F5D-4427-A961-7A085F4FDC9DQ31083068-81600E23-CF6F-4154-8C69-BD90A7A39547Q33658672-26FC7501-9267-4F27-B0DC-29558321A926Q33678040-753B03AA-C06C-437E-9D9F-F2E27DCA1583Q33987695-96120125-AED0-4D57-AEB7-DA81D0A661E0Q34051267-FDF6F784-9306-4038-ADBA-0548270F66C1Q34075151-540B94A1-1647-4A30-B80B-5ADC0119DCCCQ34135442-BCF58976-5324-4FF2-971C-3B533867FD83Q34439076-2048887A-5E89-44C7-A7B0-A28E0C3B1DAFQ34497987-35C362E3-27EA-4551-8E91-09971CDC85DCQ34582136-DA40B42C-570A-4E1D-B1E5-CEDC8D2461FBQ34707834-5A572A76-2A82-4DFF-AA33-6529735FA7C5Q34806539-9F032D60-D1C8-49E3-B053-2E6666DE7A9AQ35116107-6A09FF76-7830-469B-9839-C525A23D39ABQ35300762-AC878138-3785-4A39-BC17-A8BE05CA0358Q35655790-5FB7DABC-90BD-4C41-A846-84CFBCDC4EE7Q35880044-6BFB1765-3B2F-473B-8DF1-1B2EEF2C3D91Q36413984-0C3977C0-0DBE-41DF-9BB9-7FFE319B54C3Q36678643-4301AF86-841E-4CED-9A83-5BD8FB1DFC34Q36841980-05836E7C-1C9C-422F-8924-519FFEB9C43CQ36923286-2C1E5ECF-37F5-432A-A5EF-F29C4C215D45Q36923653-59569B1A-FD16-458B-BDED-0D3C141CA7F9Q37316559-DC8425E0-0084-41DD-AFDB-BDEB07C3ED4DQ37321080-2CED9764-AA87-40C1-B4AE-B8C574E8D278Q37327668-37DA7D61-8321-4DE7-B37C-7BF6A007000BQ37359847-A4142E3F-25B3-4753-8563-7102341C9BDFQ37610020-B0B0A5A8-8800-4B20-A884-EDAACA969D0AQ38108253-38AD1BF6-DA30-420C-A41D-234ED0A7F613Q38137862-D16907EB-BDEC-446F-9A87-469491EFB358Q38199932-3F15C9EA-4EBC-47D3-BE9A-5A3C954F07B3Q38625186-53952F75-6209-4977-8385-775099657A8DQ38756694-90BDFE7D-B556-4888-8C1B-D29A07DFB5EFQ38757854-49FB9060-E3A9-406E-99C0-F6D0E1809046Q39302186-1655978F-82A8-40DC-8FC1-0988A91618A8Q39356113-FB35C663-0B3A-42D7-8D31-4A367525C631Q40184809-7AFD9521-A986-4985-9905-9610A427CF43
P2860
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@ast
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@en
type
label
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@ast
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@en
prefLabel
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@ast
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@en
P2093
P1433
P1476
Endogenous osteonectin/SPARC/B ...... breast cancer cell metastasis.
@en
P2093
Benjamin R Kaplan-Singer
Corinne M Goldsmith
Danny R Welch
Hynda K Kleinman
Jaroslav G Vostal
Jean A Engbring
Jennifer E Koblinski
John F Harms
John T Piper
Michael Wu
P304
P356
10.1158/0008-5472.CAN-05-0807
P407
P577
2005-08-01T00:00:00Z